Clinical and economic consequences of ventilator-associated pneumonia: A systematic review

Background:Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in critically ill patients. The clinical and economic consequences of VAP are unclear, with a broad range of values reported in the literature Objective:To perform a systematic review to determine the incidence of VAP and its attributable mortality rate, length of stay, and costs. Data Source:Computerized PUBMED and MEDLINE search supplemented by manual searches for relevant articles, limited to articles published after 1990. Study Selection:English-language observational studies and randomized trials that provided data on the incidence of VAP were included. Matched cohort studies were included for calculation of attributable mortality rate and length of stay. Data Extraction:Data were extracted on patient population, diagnostic criteria for VAP, incidence, outcome, type of intensive care unit, and study design. Data Synthesis:The cumulative incidence of VAP was calculated by combining the results of several studies using standard formulas for combining proportions, in which the weighted average and variance are calculated. Results from studies comparing intensive care unit and hospital mortality due to VAP, additional length of stay, and additional days of mechanical ventilation were pooled using a random effects model, with assessment of heterogeneity. Results:Our findings indicate a) between 10% and 20% of patients receiving >48 hrs of mechanical ventilation will develop VAP; b) critically ill patients who develop VAP appear to be twice as likely to die compared with similar patients without VAP (pooled odds ratio, 2.03; 95% confidence interval, 1.16–3.56); c) patients with VAP have significantly longer intensive care unit lengths of stay (mean = 6.10 days; 95% confidence interval, 5.32–6.87 days); and d) patients who develop VAP incur ≥$10,019 in additional hospital costs. Conclusions:Ventilator-associated pneumonia occurs in a considerable proportion of patients undergoing mechanical ventilation and is associated with substantial morbidity, a two-fold mortality rate, and excess cost. Given these findings, strategies that effectively prevent VAP are urgently needed. LEARNING OBJECTIVESOn completion of this article, the reader should be able to: Define the incidence of ventilator-associated pneumonia (VAP) in mechanically ventilated patients. Explain the economic consequences of VAP. Use this information in a clinical setting. All authors have disclosed that they have no financial relationships or interests in any commercial companies pertaining to this educational activity. Wolters Kluwer Health has identified and resolved all faculty conflicts of interest regarding this educational activity. Visit the Critical Care Medicine Web site (www.ccmjournal.org) for information on obtaining continuing medical education credit.

[1]  Victoria J. Fraser,et al.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* , 2003, Critical care medicine.

[2]  H. Norton,et al.  Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. , 1996, The Journal of trauma.

[3]  C. Chastang,et al.  A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients. Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia. , 1999, American journal of respiratory and critical care medicine.

[4]  Marin H Kollef,et al.  Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Saint,et al.  The role of economic evaluation in infection control. , 2001, American journal of infection control.

[6]  R. Baughman.  Microbiologic diagnosis of ventilator-associated pneumonia. , 2005, Clinics in chest medicine.

[7]  P. Francioli,et al.  Nosocomial Pneumonia in Mechanically Ventilated Patients Receiving Antacid, Ranitidine, or Sucralfate as Prophylaxis for Stress Ulcer , 1994, Annals of Internal Medicine.

[8]  J. Eddleston,et al.  A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate‐ or ranitidine‐treated intensive care unit patients , 1991, Critical care medicine.

[9]  C. Craig,et al.  Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. , 1984, American journal of infection control.

[10]  R. Kacmarek,et al.  Weekly Ventilator Circuit Changes: A Strategy to Reduce Costs without Affecting Pneumonia Rates , 1995, Anesthesiology.

[11]  J. Dumon,et al.  Effect of ventilator-associated pneumonia on mortality and morbidity. , 1996, American journal of respiratory and critical care medicine.

[12]  R. Falcone,et al.  Occurrence of nosocomial pneumonia in mechanically ventilated trauma patients: A comparison of sucralfate and ranitidine , 1993, Critical care medicine.

[13]  R. Boots,et al.  Clinical utility of hygroscopic heat and moisture exchangers in intensive care patients. , 1997, Critical care medicine.

[14]  D. Cook,et al.  Influence of airway management on ventilator-associated pneumonia: evidence from randomized trials. , 1998, JAMA.

[15]  J. Festen,et al.  Clinical Investigations in Critical CareAntibiotic Prophylaxis of Respiratory Tract Infection in Mechanically Ventilated Patients: A Prospective, Blinded, Randomized Trial of the Effect of a Novel Regimen , 1991 .

[16]  C. Pieper,et al.  Risk factors for nosocomial pneumonia: comparing adult critical-care populations. , 1996, American journal of respiratory and critical care medicine.

[17]  J. Chastre,et al.  Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: assessment by quantitative culture of samples obtained by a protected specimen brush. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  S. Chevret,et al.  A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics. The French Study Group on Selective Decontamination of the Digestive Tract. , 1992, The New England journal of medicine.

[19]  M. Kollef,et al.  The effect of late-onset ventilator-associated pneumonia in determining patient mortality. , 1995, Chest.

[20]  A. Vuagnat,et al.  Nosocomial pneumonia and mortality among patients in intensive care units. , 1997, JAMA.

[21]  Y. Cohen,et al.  Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effects on patient colonization and incidence of nosocomial pneumonia. , 1995, American journal of respiratory and critical care medicine.

[22]  C. Perret,et al.  Safety of combined heat and moisture exchanger filters in long-term mechanical ventilation. , 1997, Chest.

[23]  C. Beck-Sague,et al.  Risk Factors for Ventilator-Associated Pneumonia in Surgical Intensive-Care–Unit Patients , 2022 .

[24]  M. Kollef,et al.  Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. , 2002, JPEN. Journal of parenteral and enteral nutrition.

[25]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[26]  Avid,et al.  A COMPARISON OF SUCRALFATE AND RANITIDINE FOR THE PREVENTION OF UPPER GASTROINTESTINAL BLEEDING IN PATIENTS REQUIRING MECHANICAL VENTILATION , 2001 .

[27]  M. Rué,et al.  Pneumonia in intubated patients: role of respiratory airway care. , 1996, American journal of respiratory and critical care medicine.

[28]  J. Rello,et al.  Risk factors for pneumonia in the intubated patient. , 2003, Infectious disease clinics of North America.

[29]  M. Farnell,et al.  Prevention of Infection in Critically Ill Patients by Selective Decontamination of the Digestive Tract , 1992, Annals of Internal Medicine.

[30]  J. de Batlle,et al.  Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. , 1997, American journal of respiratory and critical care medicine.

[31]  J. Eddleston,et al.  Prospective endoscopic study of stress erosions and ulcers in critically ill adult patients treated with either sucralfate or placebo , 1994, Critical care medicine.

[32]  P. O'Malley,et al.  Continuous subglottic suctioning for the prevention of ventilator-associated pneumonia : potential economic implications. , 2001, Chest.

[33]  D. Sofianou,et al.  Analysis of Risk Factors for Ventilator-Associated Pneumonia in a Multidisciplinary Intensive Care Unit , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[34]  M. Kollef,et al.  Mechanical ventilation with or without daily changes of in-line suction catheters. , 1997, American journal of respiratory and critical care medicine.

[35]  J. Chastre,et al.  Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. , 1989, The American review of respiratory disease.

[36]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.

[37]  M. García,et al.  Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial. , 1998 .

[38]  E. Colpart,et al.  Changing Heat and Moisture Exchangers Every 48 Hours Does Not Increase the Incidence of Nosocomial Pneumonia , 1999, Infection Control & Hospital Epidemiology.

[39]  E. Haponik,et al.  Pneumonia in intubated trauma patients. Microbiology and outcomes. , 1996, American journal of respiratory and critical care medicine.

[40]  A. Dauber,et al.  Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination (SOD) , 1997, Intensive Care Medicine.

[41]  C. Metz,et al.  Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related upper gastrointestinal bleeding: a prospective, multicenter, double-blind, randomized trial. The Ranitidine Head Injury Study Group. , 1993, Critical care medicine.

[42]  R. Rodríguez-Roisín,et al.  Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. , 1990, The American review of respiratory disease.

[43]  J. Rello,et al.  A 7-year study of severe hospital-acquired pneumonia requiring ICU admission , 2003, Intensive Care Medicine.

[44]  R. Auckenthaler,et al.  Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. A randomized, placebo-controlled, double-blind clinical trial. , 1991, JAMA.

[45]  M. Schumacher,et al.  Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[46]  D. Teres,et al.  Pneumonia in an intensive care unit. A 30-month experience. , 1974, Archives of internal medicine.

[47]  M. Kollef,et al.  A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier with heated-water humidification in mechanically ventilated patients. , 1998, Chest.

[48]  Z. Memish,et al.  A randomized clinical trial to compare the effects of a heat and moisture exchanger with a heated humidifying system on the occurrence rate of ventilator-associated pneumonia , 2001 .

[49]  J. Rello,et al.  Continuous Aspiration of Subglottic Secretions in Preventing Ventilator-Associated Pneumonia , 1995, Annals of Internal Medicine.

[50]  T. Boulain,et al.  Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: A prospective case-control study , 2001, Critical care medicine.

[51]  G. O’Keefe,et al.  Incidence of infectious complications associated with the use of histamine2-receptor antagonists in critically ill trauma patients. , 1998, Annals of surgery.

[52]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[53]  J. L. Rodriguez,et al.  Pneumonia: incidence, risk factors, and outcome in injured patients. , 1990 .

[54]  M. Kollef,et al.  Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. , 1997, American journal of respiratory and critical care medicine.

[55]  N. E. Breslow.  Statistical Methods in Cancer Research , 1986 .

[56]  C. Guérin,et al.  Prevention of nosocomial pneumonia in intubated patients: Respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis , 2005, Intensive Care Medicine.

[57]  T. Scalea,et al.  A time-dependent analysis of intensive care unit pneumonia in trauma patients. , 2004, The Journal of trauma.

[58]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[59]  R. Rodríguez-Roisín,et al.  Nosocomial pneumonia. A multivariate analysis of risk and prognosis. , 1988, Chest.

[60]  B. Quinio,et al.  Selective decontamination of the digestive tract in multiple trauma patients. A prospective double-blind, randomized, placebo-controlled study. , 1996, Chest.

[61]  B. Make,et al.  Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. , 1986, The American review of respiratory disease.

[62]  Miquel Ferrer,et al.  Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial , 1999, The Lancet.

[63]  J. Rello,et al.  Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. , 1991, Chest.

[64]  C. Alex,et al.  Extending ventilator circuit change interval beyond 2 days reduces the likelihood of ventilator-associated pneumonia. , 1998, Chest.

[65]  D. Sessler,et al.  Risk factors for early-onset, ventilator-associated pneumonia in critical care patients: selected multiresistant versus nonresistant bacteria. , 2000, Anesthesiology.

[66]  Steven B. Johnson,et al.  Closed versus open endotracheal suctioning: Costs and physiologic consequences , 1994, Critical care medicine.

[67]  M. Kollef.  The prevention of ventilator-associated pneumonia. , 1999, The New England journal of medicine.

[68]  M. Rué,et al.  Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent. , 1997, Critical care medicine.

[69]  R. Weinstein,et al.  A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  G. Guyatt,et al.  A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. , 1998, The New England journal of medicine.

[71]  D. Dreyfuss,et al.  Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. , 1991, The American review of respiratory disease.

[72]  G. Van den Berghe,et al.  Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit. , 1997, Critical care medicine.

[73]  T. Sundt,et al.  A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. , 1999, Chest.

[74]  J. Rello,et al.  Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. , 1993, Chest.

[75]  R. Baughman.  Diagnosis of ventilator-associated pneumonia. , 2003, Microbes and infection.

[76]  S. S. Zeitoun,et al.  A prospective, randomized study of ventilator-associated pneumonia in patients using a closed vs. open suction system. , 2003, Journal of clinical nursing.

[77]  P. Lejeune,et al.  Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. , 1997, The Journal of trauma.

[78]  O. Kirton,et al.  A prospective, randomized comparison of an in-line heat moisture exchange filter and heated wire humidifiers: rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion. , 1997, Chest.

[79]  M. Kollef,et al.  Mechanical Ventilation with or without 7-Day Circuit Changes , 1995, Annals of Internal Medicine.

[80]  F. V. van Tiel,et al.  The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated ICU patients. A stratified, randomized, double-blind study of sucralfate versus antacids. , 1995, American journal of respiratory and critical care medicine.

[81]  Jordi Rello,et al.  Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. , 2002, Chest.

[82]  D. Craven.  Epidemiology of ventilator-associated pneumonia. , 2000, Chest.

[83]  J. Rello,et al.  Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. , 1994, American journal of respiratory and critical care medicine.

[84]  D. Bowton.  Nosocomial pneumonia in the ICU--year 2000 and beyond. , 1999, Chest.

[85]  Gordon Guyatt,et al.  Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients , 1998, Annals of Internal Medicine.

[86]  N. Yurtseven,et al.  Ventilator-associated pneumonias in a cardiothoracic surgery centre postoperative intensive care unit. , 2001, The Journal of hospital infection.

[87]  F Mosteller,et al.  Some Statistical Methods for Combining Experimental Results , 1990, International Journal of Technology Assessment in Health Care.

[88]  Yves Cohen,et al.  Mortality associated with late-onset pneumonia in the intensive care unit: results of a multi-center cohort study , 2002, Intensive Care Medicine.

[89]  C. Vandenbroucke-Grauls,et al.  A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. , 2002, Chest.

[90]  S. Hugonnet,et al.  Ventilator-associated pneumonia: caveats for benchmarking , 2003, Intensive Care Medicine.

[91]  M. Kollef,et al.  A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. , 2000, Chest.

[92]  R. Ferrer,et al.  Ventilator-associated pneumonia: incidence, risk factors, and microbiology. , 2000, Seminars in respiratory infections.

[93]  M. T. Durán,et al.  Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract , 1992, Intensive Care Medicine.

[94]  Jenny A Darvas,et al.  The closed tracheal suction catheter: 24 hour or 48 hour change? , 2003, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.

[95]  J. Roustan,et al.  Comparison of hydrophobic heat and moisture exchangers with heated humidifier during prolonged mechanical ventilation , 2005, Intensive Care Medicine.

[96]  F. Abroug,et al.  Incidence and risk factors of ventilator-associated pneumonia: a one-year prospective survey , 1996 .

[97]  C. Kirsch,et al.  The incidence of ventilator-associated pneumonia and success in nutrient delivery with gastric versus small intestinal feeding: A randomized clinical trial , 2000, Critical care medicine.

[98]  P. Montravers,et al.  Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. , 1993, The American journal of medicine.

[99]  A. Arroliga,et al.  Weekly versus daily changes of in-line suction catheters: impact on rates of ventilator-associated pneumonia and associated costs. , 2003, Respiratory care.

[100]  W. Dunn,et al.  Diagnosing ventilator-associated pneumonia: the role of bronchoscopy. , 1994, Mayo Clinic proceedings.

[101]  S. Hayek,et al.  Ventilator-Associated Pneumonia at a Tertiary-Care Center in a Developing Country: Incidence, Microbiology, and Susceptibility Patterns of Isolated Microorganisms , 2003, Infection Control & Hospital Epidemiology.

[102]  Z. Memish,et al.  The Incidence and Risk Factors of Ventilator-Associated Pneumonia in a Riyadh Hospital , 2000, Infection Control & Hospital Epidemiology.

[103]  P. D. de Leeuw,et al.  Intermittent enteral feeding: the influence on respiratory and digestive tract colonization in mechanically ventilated intensive-care-unit patients. , 1996, American journal of respiratory and critical care medicine.

[104]  Hajo A. Bruining,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995 .

[105]  G. Campbell,et al.  Hospital-acquired pneumonia: epidemiology, etiology, and treatment. , 1998, Infectious disease clinics of North America.

[106]  R. Rodríguez-Roisín,et al.  Utility of Selective Digestive Decontamination in Mechanically Ventilated Patients , 1994, Annals of Internal Medicine.

[107]  V. Deroin,et al.  Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: A double‐blind, randomized, placebo‐controlled study , 1993, Critical care medicine.

[108]  R. Woolson,et al.  Hospital-acquired pneumonia. Attributable mortality and morbidity. , 1989, American journal of epidemiology.

[109]  ICU-Acquired Pneumonia Study Group,et al.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit , 1996, Intensive Care Medicine.

[110]  A. Torres,et al.  Hospital-acquired pneumonia: etiologic considerations. , 2003, Infectious disease clinics of North America.

[111]  A. Ambergen,et al.  Risk factors for pneumonia, and colonization of respiratory tract and stomach in mechanically ventilated ICU patients. , 1996, American journal of respiratory and critical care medicine.

[112]  A. Stamm,et al.  Prospective, Randomized Study of Ventilator-Associated Pneumonia in Patients With One Versus Three Ventilator Circuit Changes Per Week , 1996, Infection Control & Hospital Epidemiology.

[113]  F. V. van Tiel,et al.  Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. , 2001, American journal of respiratory and critical care medicine.

[114]  M. Kollef,et al.  Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. , 1997, Chest.

[115]  G. Divine,et al.  Prophylaxis for Stress-related Gastric Hemorrhage in the Medical Intensive Care Unit , 1994, Annals of Internal Medicine.

[116]  E. Bouza,et al.  Ventilator-associated pneumonia after heart surgery: A prospective analysis and the value of surveillance* , 2003, Critical care medicine.

[117]  İ. Köksal,et al.  Acute stress bleeding prophylaxis with sucralfate versus ranitidine and incidence of secondary pneumonia in intensive care unit patients , 1995, Intensive Care Medicine.

[118]  M. Kollef.  Ventilator-Associated Pneumonia , 2005 .

[119]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[120]  T. Katostaras,et al.  Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. , 2003, Respiratory care.

[121]  E. Hanisch,et al.  A randomized, double-blind trial for stress ulcer prophylaxis shows no evidence of increased pneumonia. , 1998, American journal of surgery.

[122]  M. Kollef,et al.  The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. , 2001, Chest.

[123]  H. Humphreys,et al.  A controlled trial of selective decontamination of the digestive tract in intensive care and its effect on nosocomial infection. , 1992, The Journal of antimicrobial chemotherapy.

[124]  S. Chevret,et al.  Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. , 1996, American Journal of Respiratory and Critical Care Medicine.

[125]  G. Bhave,et al.  Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial , 1992, Critical Care Medicine.